Lacosamide Solution
Product Images NDC 31722-627

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 31722-627). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lacosamidefigure1 (Lacosamidefigure1)

A bar chart comparing seizure reduction percentages from baseline across four studies. Each study contrasts placebo and Lacosamide groups at various doses. Lacosamide consistently shows higher seizure reduction percentages (ranging approximately 35%-40%) compared to placebo (ranging approximately 10%-26%), indicating efficacy in reducing seizures orally.*

FDA Label Image

Lacosamidefigure2 (Lacosamidefigure2)

A line graph depicting cumulative responder rates for lacosamide at doses of 200 mg/day, 400 mg/day, and 600 mg/day compared to placebo. The x-axis shows the percent of patients, and the y-axis shows the responder rate (equal to or greater improvement). The three lacosamide treatment lines show higher responder rates than placebo across the patient population.*

FDA Label Image

Lacosamidestructure (Lacosamidestructure)

Chemical structure diagram of lacosamide, depicting its molecular configuration including functional groups and bonding arrangements, as seen in the image.*

FDA Label Image

Lacosamidecamberlogo1 (Lacosamidecamberlogo1)

FDA Label Image

Lacosamideos200mlcartonlabel (Lacosamideos200mlcartonlabel)

Packaging label for Lacosamide Oral Solution USP 10 mg/mL by Camber Pharmaceuticals, Inc. The label includes dosing information, storage instructions, and safety warnings. The product is supplied in a 200 mL bottle with NDC 31722-627-26. The label features a barcode and manufacturing details from Hetero Labs Limited, India.*

FDA Label Image

Lacosamideos200mlcontlabel (Lacosamideos200mlcontlabel)

Label for Lacosamide Oral Solution 10 mg/mL by Camber Pharmaceuticals, Inc. The label indicates a 200 mL oral solution with a storage temperature range and dosing instructions reference. It includes NDC 31722-627-26 and pharmacist attention notes. The label also shows manufacturing information and a barcode.*

FDA Label Image

Lacosamideos465mlcartonlabel (Lacosamideos465mlcartonlabel)

Packaging label for Lacosamide Oral Solution, USP 10 mg/mL by Camber Pharmaceuticals, Inc. Label shows 465 mL bottle size and states the active ingredient concentration. Includes manufacturer information for Camber Pharmaceuticals in Piscataway, NJ, with secondary manufacturer Hetero Labs Limited, India. The label also provides storage instructions, pharmacist attention notice, and a medication guide URL.*

FDA Label Image

Lacosamideos465mlcontlabel (Lacosamideos465mlcontlabel)

Label for Lacosamide Oral Solution, USP, 10 mg/mL by Camber Pharmaceuticals, Inc. The oral solution is contained in a 465 mL bottle. The label includes dosing and storage instructions, barcode, and manufacturing information by Hetero Labs Limited in India, distributed by Camber Pharmaceuticals in Piscataway, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.